| Group A (benign breast disease) | Group B (breast cancer patients) |
---|---|---|
Number of patients | 6 | 10 |
Median age (years) | 37 (range, 28–47) | 55 (range, 36–76) |
Disease | Fibroadenoma | Invasive ductal carcinoma |
Disease site | ||
Right breast | 3/6 | 8/10 |
Left breast | 3/6 | 2/10 |
Surgical procedure | ||
WLE | 6/6 | - |
WLE + ALND | - | 5/10 |
MRM + ALND | - | 5/10 |
T stage | ||
T1 | - | 0/10 |
T2 | - | 5/10 |
T3 | - | 5/10 |
N status | ||
N0 | - | 6/10 |
N1 | - | 3/10 |
N2 | - | 1/10 |
Grade | ||
2 | - | 9/10 |
3 | - | 1/10 |
Hormonal receptor status | ||
ER+ | - | 10/10 |
PR+ | - | 10/10 |
HER2 status | ||
0 | - | 4/10 |
1 | - | 2/10 |
2 | - | 4/10 |
Blood samples | PRE, day 3 | PRE, day 3, day 7 |